HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bai, A. Articles by Forman, J. Search for Related Content PubMed PubMed Citation Articles by Bai, A. Articles by Forman, J.

Factors Controlling the Trafficking and Processing of a Leader-Derived Peptide Presented by Qa-1¹

Ailin Bai^*,, Carla J. Aldrich and James Forman^2,*

^* Center for Immunology and Immunology Graduate Program, University of Texas Southwestern Medical Center, Dallas, TX 75235; and Department of Microbiology and Immunology, Indiana University School of Medicine, Evansville Center, Evansville, IN 47712

Many leader-derived peptides require TAP for presentation by class I molecules. This TAP dependence can either be ascribed to the inability of proteases resident in the endoplasmic reticulum (ER) to trim leader peptide precursors into the appropriate epitope or the failure of a portion of the leader segment to gain access to the lumen of the ER. Using the Qa-1 binding epitope, Qdm derived from a class Ia leader as a model, we show that many cell types lack ER protease activity to trim this peptide at its C terminus. However, both T1 and T2 cells contain appropriate protease activity to process the full length D^d leader (DL) when introduced into the ER lumen. Nevertheless, both T1 cells treated with the TAP inhibitor ICP47 and TAP^- T2 cells fail to present this epitope from either the intact D^d molecule or a minigene encoding the DL. This indicates that the portion of the leader containing Qdm does not gain access to the ER. However, changing the Arg at P7 of the DL to a Cys can alter its trafficking and allows for TAP-independent presentation of the Qdm epitope.

This article has been cited by other articles:

				J. Yan, V. V. Parekh, Y. Mendez-Fernandez, D. Olivares-Villagomez, S. Dragovic, T. Hill, D. C. Roopenian, S. Joyce, and L. Van Kaer In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules J. Exp. Med., March 20, 2006; 203(3): 647 - 659. [Abstract] [Full Text] [PDF]

				S. Huang, S. Gilfillan, M. Cella, M. J. Miley, O. Lantz, L. Lybarger, D. H. Fremont, and T. H. Hansen Evidence for MR1 Antigen Presentation to Mucosal-associated Invariant T Cells J. Biol. Chem., June 3, 2005; 280(22): 21183 - 21193. [Abstract] [Full Text] [PDF]

				L. Li, B. A. Sullivan, C. J. Aldrich, M. J. Soloski, J. Forman, A. G. Grandea III, P. E. Jensen, and L. Van Kaer Differential Requirement for Tapasin in the Presentation of Leader- and Insulin-Derived Peptide Antigens to Qa-1b-Restricted CTLs J. Immunol., September 15, 2004; 173(6): 3707 - 3715. [Abstract] [Full Text] [PDF]

				S.-J. Kang and P. Cresswell Calnexin, Calreticulin, and ERp57 Cooperate in Disulfide Bond Formation in Human CD1d Heavy Chain J. Biol. Chem., November 15, 2002; 277(47): 44838 - 44844. [Abstract] [Full Text] [PDF]

				M. K. Lemberg, F. A. Bland, A. Weihofen, V. M. Braud, and B. Martoglio Intramembrane Proteolysis of Signal Peptides: An Essential Step in the Generation of HLA-E Epitopes J. Immunol., December 1, 2001; 167(11): 6441 - 6446. [Abstract] [Full Text] [PDF]